Home
Market Capitalization of Piramal Pharma Ltd

Piramal Pharma Ltd
NSE: PPLPHARMA
Market Cap
Key Highlights
- The Market Cap of Piramal Pharma Ltd is ₹ 29146 crore as of 24 Apr 25 .
- The Latest Trading Price of Piramal Pharma Ltd is ₹ 219.85 as of 24 Apr 15:30 .
- The Dividend Payouts of Piramal Pharma Ltd is ₹ 0.11 as of Jul 12, 2024 .

Piramal Pharma Ltd
NSE: PPLPHARMA
Share Price
Market Price of Piramal Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
24 Apr 2025 | 219.85 |
23 Apr 2025 | 223.65 |
22 Apr 2025 | 224.55 |
21 Apr 2025 | 220.8 |
17 Apr 2025 | 220.15 |
16 Apr 2025 | 221.8 |
15 Apr 2025 | 222.55 |
11 Apr 2025 | 219.65 |
09 Apr 2025 | 208.3 |
08 Apr 2025 | 221.45 |
SWOT Analysis Of Piramal Pharma Ltd
BlinkX Score for Piramal Pharma Ltd
Asset Value vs Market Value of Piramal Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Piramal Pharma Ltd
Historical P/E Ratio of Piramal Pharma Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Piramal Pharma Ltd
Historical Revenue of Piramal Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Piramal Pharma Ltd
Historical EBITDA of Piramal Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Piramal Pharma Ltd
Historical Net Profit of Piramal Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Piramal Pharma Ltd

Piramal Pharma Ltd
NSE: PPLPHARMA
DIVIDENDPAYOUT
About Piramal Pharma Ltd
- Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
- It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
- In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. Piramal Pharma Solution provides integrated drug discovery, development, and manufacturing services for both drug substances, i.e. active pharmaceutical ingredients (APIs) and drug products, i.e. formulations across the life cycle of a molecule, from discovery and clinical development to commercial launch.
Piramal Pharma Ltd News Hub
Piramal Pharma receives SBTi validation for its GHG commitment
Piramal Pharma has embarked on its sustainability journey as the Science Based Targets initiative (S
Read more
17 Sept 24
Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility
Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization
Read more
30 Sept 24
Piramal Pharma to discuss results
Piramal Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025. Powe
Read more
14 Jan 25
Piramal Pharma to declare Quarterly Result
Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October 2024. Powe
Read more
15 Oct 24